The European Society for Medical Oncology (ESMO) has announced that Professor Jean-Charles Soria will be the new Editor-in-Chief of Annals of Oncology, effective January 2014.
Annals of Oncology is ESMO's flagship scientific journal, established to keep medical oncologists at the cutting edge of new research developments. The journal is among the top twenty oncology journals worldwide and its impact factor is now 7.384.
Prof. Soria is a medical oncologist with particular expertise in lung cancer. He was recently appointed Chair of the new Drug Development Department (DITEP) at Gustave Roussy Cancer Center in Paris, France. His top priority as Editor-in-Chief of Annals of Oncology will be to identify ways to push the impact factor even higher. He aims to increase the number of high-quality reviews and guidelines, including official ESMO Clinical Practice Guidelines, the reference standard for practicing clinicians. He also aims to attract more randomised trials -including the negative ones, and ad hoc editorials to dig into crucial issues facing medical oncology today. New sections will be developed to position the journal fully in the 21st century.
